NPI registry status
Active
2026 NPPES data Hematology (Internal Medicine) Physician NPI 1508847625 M.D.
Verify on CMS → Labib Hashimi, M.D.
Hematology (Internal Medicine) Physician in Chino, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 1,436 in Hematology (Internal Medicine) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
600
Medicare Part D claims · 125 beneficiaries · Hematology (Internal Medicine) Physician avg: 693
Generic prescribing
73%
generic claims · 27% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$5.2K
176 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Labib Hashimi, M.D. filed 600 Medicare Part D claims in 2023 as a Hematology (Internal Medicine) Physician in Chino, California, prescribing 73% generic.
- 600
- Part D claims, 2023
- 73%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Labib Hashimi, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023, across all CMS prescribers nationally
600 Top 31% higher than 69% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
✓
Board certification likely (heuristic, not verified)
Labib Hashimi, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Labib Hashimi, M.D.?
Quality data not reportedPrimary specialty
Hematology (Internal Medicine) Physician
Medicare Part D claims
600 13% vs specialty avg
Specialty distribution in California
How Hematology (Internal Medicine) Physician compares to other specialties among California providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Hematology (Internal Medicine) Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Labib Hashimi, M.D. appears in the CMS NPPES registry as a Hematology (Internal Medicine) Physician provider holding M.D. credentials at 13768 ROSWELL AVE, Chino, CA, 91710, with a listed phone of (909) 591-0814. NPI 1508847625 was issued on 11/07/2005.
Medicare Part D records for calendar year 2023 show 600 prescription claims written by this provider, covering 125 Medicare beneficiaries and totaling roughly $2.0 million in drug spend, split 27% brand-name and 73% generic by claim count, with an opioid prescribing rate of 4.7%.
Hematology (Internal Medicine) Physician is a narrow specialty nationwide, with 1,436 enrolled providers across 50 states and an average of 693 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1508847625 |
|---|---|
| Specialty | Hematology (Internal Medicine) Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 11/07/2005 |
Hospital and facility affiliations
Facilities where Labib Hashimi, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
The Oncology Institute CA, A Professional Corporation
Riverside, CA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Labib Hashimi, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$5.2K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Labib Hashimi, M.D.. To verify Labib Hashimi, M.D.'s current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Labib Hashimi, M.D. - brand share 27.0%
Hematology (Internal Medicine) Physician average
27% brand-name claims vs 73% generic, on 600 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
600
Total Claims
$2.0M
Total Drug Cost
125
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 925
- Total Day Supply
- 26,075
- Brand vs Generic
- 27% brand / 73% generic
- Brand Drug Cost
- $1.9M
- Generic Drug Cost
- $26K
- Opioid Claims
- 28 (4.7% rate)
Patient Demographics
- Average Patient Age
- 74.4 years
- Avg HCC Risk Score
- 2.27
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 13, 65-74: 49, 75-84: 44, 85+: 19
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Labib Hashimi, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
102 claims
- Jakafi
Jakafi
53 claims
- Alendronate Sodium 37
Alendronate Sodium
37 claims
- Hydroxyurea 29
Hydroxyurea
29 claims
- Letrozole 21
Letrozole
21 claims
- Keytruda 18
Keytruda
18 claims
- Exemestane 16
Exemestane
16 claims
- Tamoxifen Citrate 16
Tamoxifen Citrate
16 claims
| Drug | Claims |
|---|---|
| Anastrozole | 102 |
| Jakafi Ruxolitinib Phosphate | 53 |
| Alendronate Sodium | 37 |
| Hydroxyurea | 29 |
| Letrozole | 21 |
| Keytruda Pembrolizumab | 18 |
| Exemestane | 16 |
| Tamoxifen Citrate | 16 |
| Potassium Chloride | 15 |
| Ondansetron Hcl | 14 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Hematology (Internal Medicine) Physician in CA →
All providers in California →
Compare specialties →
Hematology (Internal Medicine) Physician Overview
How Labib Hashimi, M.D. fits within the Hematology (Internal Medicine) Physician landscape nationally.
1,436
Hematology (Internal Medicine) Physician Providers in US
50
States with Hematology (Internal Medicine) Physician
693
Avg Claims per Provider
Labib Hashimi, M.D.'s 600 claims are below the specialty average of 693.
Nearby Hematology (Internal Medicine) Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Hashimi.
Dr. Haifaa Abdulhaq
MD
Fresno, CA
Dr. John Adamson
MD
San Diego, CA
Dr. Idoroenyi Amanam
M.D.
Duarte, CA
Dr. Ian Anderson
M.D.
Santa Rosa, CA
Dr. Sally Arai
MD
Stanford, CA
Compare Hematology (Internal Medicine) Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the California medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Hematology (Internal Medicine) Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore California
Frequently Asked Questions
What is Labib Hashimi, M.D.'s specialty? ▼
Labib Hashimi, M.D. specializes in Hematology (Internal Medicine) Physician and practices in Chino, California. Credentials: M.D..
How much does Labib Hashimi, M.D. prescribe under Medicare Part D? ▼
In 2023, Labib Hashimi, M.D. wrote 600 Medicare Part D claims totaling $2.0M in drug costs for 125 beneficiaries.
Where is Labib Hashimi, M.D. located? ▼
Labib Hashimi, M.D. is located at 13768 ROSWELL AVE, Chino, CA, 91710. Phone: (909) 591-0814.
What is Labib Hashimi, M.D.'s NPI number? ▼
Labib Hashimi, M.D.'s National Provider Identifier (NPI) is 1508847625, issued on 11/07/2005.
Does Labib Hashimi, M.D. prescribe more brand-name or generic drugs? ▼
Labib Hashimi, M.D.'s prescribing is 27% brand-name and 73% generic drugs by claim count, with $1.9M in brand drug costs.
Does Labib Hashimi, M.D. prescribe opioids? ▼
Yes, Labib Hashimi, M.D. had 28 opioid claims in 2023 with an opioid prescribing rate of 4.7%.
How many Hematology (Internal Medicine) Physician providers are there in the US? ▼
There are 1,436 Hematology (Internal Medicine) Physician providers across 50 states in the US. The average Hematology (Internal Medicine) Physician provider writes 693 Medicare Part D claims per year.
What drugs does Labib Hashimi, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Labib Hashimi, M.D.'s most frequently prescribed drugs include Anastrozole, Jakafi, Alendronate Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Labib Hashimi, M.D. accept Medicare? ▼
Labib Hashimi, M.D. appears in CMS Medicare data with 600 Part D claims and 125 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Labib Hashimi, M.D.'s credentials? ▼
Labib Hashimi, M.D.'s NPI is 1508847625 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.